AUROPHARMA.NS Profit & Loss

Aurobindo Pharma Ltd.

Profit & Loss · 4 years on file (FY2022-23 to FY2025-26) · fetched 2026-08-23 21:36

Line item	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹248.55 Bn	₹290.02 Bn	₹317.24 Bn	₹336.53 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹2.91 Bn	₹5.57 Bn	₹6.22 Bn	₹4.92 Bn	OtherIncome
Total Income	₹251.46 Bn	₹295.59 Bn	₹323.46 Bn	₹341.45 Bn	Income
Cost of Materials Consumed	₹96.53 Bn	₹107.76 Bn	₹107.37 Bn	₹103.05 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹20.50 Bn	₹27.73 Bn	₹28.87 Bn	₹34.78 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹-4.10 Bn	₹-9.46 Bn	₹-5.98 Bn	₹-2.95 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹35.22 Bn	₹39.23 Bn	₹44.76 Bn	₹51.90 Bn	EmployeeBenefitExpense
Finance Costs	₹1.40 Bn	₹2.90 Bn	₹4.57 Bn	₹3.84 Bn	FinanceCosts
Depreciation and Amortisation	₹12.45 Bn	₹15.22 Bn	₹16.49 Bn	₹17.78 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹63.21 Bn	₹66.33 Bn	₹76.39 Bn	₹81.29 Bn	OtherExpenses
Total Expenses	₹225.22 Bn	₹249.70 Bn	₹272.48 Bn	₹289.70 Bn	Expenses
Profit Before Exceptional Items and Tax	₹26.24 Bn	₹45.89 Bn	₹50.98 Bn	₹51.76 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹0.00 Bn	₹-1.92 Bn	₹0.00 Bn	₹-0.65 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹26.24 Bn	₹43.97 Bn	₹50.98 Bn	₹51.10 Bn	ProfitBeforeTax
Tax Expense	₹6.85 Bn	₹12.11 Bn	₹15.83 Bn	₹16.09 Bn	TaxExpense
Net Profit (incl. minority interest)	₹19.28 Bn	₹31.69 Bn	₹34.84 Bn	₹35.03 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	₹19.27 Bn	₹31.73 Bn	₹34.86 Bn	₹35.05 Bn	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹32.90	₹54.16	₹59.81	₹60.34	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹32.90	₹54.16	₹59.81	₹60.34	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from AUROPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).